Publication Cover
Annals of Tropical Paediatrics
International Child Health
Volume 21, 2001 - Issue 3
12
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Myoclonic seizure following intravenous verapamil injection: case report and review of the literature

&
Pages 271-272 | Accepted 01 Apr 2001, Published online: 13 Jul 2016

References

  • Wilkinson JL. Management of paroxysmal tachycardia. Arch Dis Child 1983; 58: 945–6.
  • Hicks CB, Abraham K. Verapamil and myoclonic dystonia. Ann Intern Med 1985; 103: 154.
  • Kirk R, Gibbs JL, Thomas R, et al. Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child 1987; 62: 1265–6.
  • Solar-Solar J, Sagrista-Sauleda J, Cabreza A, et al. Effect of verapamil in infants with paroxysmal supraventricular tachycardia. Circulation 1979; 59: 876–9.
  • Shahar E, Barzilay Z, Frand M. Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children. J Pediatr 1981; 98: 323–6.
  • Kumana CR, Mahon WA. Bizarre perceptual disorder of extremities in patients taking verapamil. Lancet 1981; 13: 1324–5.
  • Singh BN, Collett JT, Chew CYC. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980; 22: 243–301.
  • Dreifuss FE. Focal and multifocal cortical seizures. In: Swaiman KF, Wright FS. The Practice of Pediatric Neurology. St Louis: CV Mosby, 1982; 1036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.